Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 211087

Expand all

POTASSIUM CHLORIDE 10MEQ (POTASSIUM CHLORIDE)
14.9MG/ML
Marketing Status: Prescription

Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 10MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 14.9MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A211087
Product Number: 001
Approval Date: Sep 9, 2020
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

POTASSIUM CHLORIDE 10MEQ (POTASSIUM CHLORIDE)
746MG/100ML
Marketing Status: Prescription

Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 10MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 746MG/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A211087
Product Number: 002
Approval Date: Sep 9, 2020
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

POTASSIUM CHLORIDE 20MEQ (POTASSIUM CHLORIDE)
29.8MG/ML
Marketing Status: Prescription

Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 20MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 29.8MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A211087
Product Number: 003
Approval Date: Sep 9, 2020
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

POTASSIUM CHLORIDE 20MEQ (POTASSIUM CHLORIDE)
1.49GM/100ML
Marketing Status: Prescription

Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 20MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1.49GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A211087
Product Number: 005
Approval Date: May 7, 2021
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

POTASSIUM CHLORIDE 40MEQ (POTASSIUM CHLORIDE)
2.98GM/100ML
Marketing Status: Prescription

Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE 40MEQ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.98GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A211087
Product Number: 004
Approval Date: Sep 9, 2020
Applicant Holder Full Name: FRESENIUS KABI USA LLC
Marketing Status:  Prescription
Patent and Exclusivity Information